Claim OwnershipNGMC Continuing Medical Education
Subscribed: 2Played: 54
Subscribe
© All content presented is considered property of Northeast Georgia Health System.
Description
This channel contains presentations that are a part of the CME offerings of Northeast Georgia Health System, Inc. Enduring CME material expires two years from presentation date.
137 Episodes
Reverse
Speaker: Olivia Peralta, MD
IM Resident, PGY-3
No Disclosures
Objectives:
-Pathophysiology of anaerobic and aerobic metabolism
- Prevalence of Lactic Acidosis and Prognostic Indications
-Types of Lactic Acidosis
-Role of Thiamine in the setting of persistent Lactic Acidosis
-Approach to and management of Lactic Acidosis
Speaker: Judy Mikhail, PhD, MBA, RN
Editor-in-Chief, Journal of Trauma Nursing
Program Manager, Michigan Trauma
Quality Improvement Program
University of Michigan
Disclosures: None
Objectives:
• Identify the outline of a scholarly article, including how to formulate a
compelling introduction, effectively discuss methods, present results, and
conclude with a powerful discussion that can stimulate further research.
• Employ strategies for clarity, conciseness and precision in one’s writing,
including identifying and rectifying common pitfalls such as passive voice,
excessive jargon or verbosity.
• Familiarize oneself with the submission and publication process, including
publication ethics and the stages of peer review.
Speaker:
Brian Schuler, MD
System Director, Clinical Cardiac Electrophysiology WellSpan Health, York, PA
Disclosures:
Speaker and Consultant: Canon Medical, USA
Speaker, Consultant, and Medical Advisory Board: Boston Scientific
Objectives:
•Demonstrate the utility of the CT-Angio Suite for EP/cath procedures.
•Review data strongly suggesting CT-guided LAAO is the gold standard of PDL prevention.
•Review data demonstrating CT-Angio Suite is a fee-for-service and value-based care champion.
Dr. Bedri Yusuf, Andrei Boyarshinov, Steve Kelly, Kassandra Lawson, Dr. Hellen Ransom, and Dr. Janeane Walker
Steve Kelly, Compliance
Kassandra Lawson, Associate Counsel, Legal Department
Hellen Ransom, PhD, Clinical Ethicist
Bedri Yusuf, MD, Chief Physician Executive
Janeane Walker, PhD, RN, Director Faculty Development and Educational Outcomes
Speaker: Ruben Ruiz Vega, MD
IM Resident, PGY-3
No Disclosures
Objectives:
• Understand the concept of ctDNA by defining what it is and learning its
relevance in cancer research and diagnostics.
• Grasp the clinical applications of ctDNA by discovering how ctDNA is utilized in
cancer diagnosis, prognosis, treatment monitoring and early detection, and the
potential impact on patient care.
• Identify the challenges and limitations of working with ctDNA, including issues
related to sensitivity and specificity.
• Explore ctDNA’s role in personalized medicine and its potential for other
medical applications.
Speaker: Aleksandros Mihilli, MD
PGY-3 IM Resident
No disclosures
Objectives:
•Understand how GLP-1RA function, and their use in diabetes and weight loss
•Compare the available GLP-1RA in terms of efficacy, and when to use which
•Look at future advancements in the field and what research is currently ongoing
Speaker:
Travis Dobbs, MS, APRN, FNP-C
No disclosures
Speaker: Alix Schnibben, PharmD, BCACP, CTTS
Director, Clinical Quality and Ambulatory Pharmacy Services
Ambulatory Care Pharmacist
No disclosures.
Objectives:
-Discuss the growing Opioid Epidemic and related statistics.
-Review Federal and Georgia State laws and NGHS policies regarding prescribing controlled substances.
-Review how to calculate Morphine Milliequivalent Per Day (MME/day).
-Summarize the new 2022 CDC Guidelines for Prescribing Opioids for Chronic Pain.
-Discuss nonpharmacologic, nonopioid and opioid pharmacologic therapy options.
-Discuss Office Visit Workflow for treatment of chronic pain with opioids.
Speaker:
Glen Henry, MD; Medical Director, Cath Lab, Georgia Heart Institute
Sanjay Lall, MD, MBA, FACC; Cardiologist; Georgia Heart Institute
Speakers have no disclosures
Objectives:
• Discuss the burden and impact of hypertension.
• Discuss the definition and diagnostic evaluation of hypertension.
• Discuss the treatment of hypertension.
Speaker: Budder Siddiqui, MD
Infectious Diseases, Northeast Georgia Medical Center
No disclosures
Objectives:
• To identify the causes of emerging global infections
• To discuss ways to prevent future pandemics
Brittany Parker, MD NGPG Family Medicine
Tembele Yangandawele, MD NGPG Family Medicine
No Disclosures
Objectives:
•Review epidemiology of maternal opioid use disorder
•Understand pharmacology and use of buprenorphine/naloxone in opioid treatment
•Overview of maternal comprehensive opioid addiction program
•In-depth review of medication initiation and maintenance during pregnancy and postpartum period
•Understand monitoring parameters during initiation and discontinuation
•Review of Neonatal Abstinence Syndrome (NAS) Ramification
Speaker:
Kevin Kalinsky, MD, MS
Professor of Medicine
Director, Glenn Family Breast Center
Director, Breast Medical Oncology
Louisa and Rand Glenn Family Chair in Breast Cancer Research
Objectives:
- To learn about currently approved ADCs in HER2- breast cancer
- To have further understanding of HER2 low breast cancer
- To learn about future ADCs
Disclosures:
Advisory/Consulting: Genentech/Roche, Immunomedics, Seattle Genetics, Daiichi Sankyo, Puma Biotechnology, Mersana, Menarini Silicon Biosystems, Myovant Sciences, Takeda
Speaker: Supriya Mannepalli, MD
Disclosures: None
Objectives:
- Review Infection prevention and control data for 2013 Fiscal year for hospital acquired infections
- Review CDC definitions and best practice prevention bundles for hospital acquired infections
- Discuss upcoming changes to CDC definitions for CLABSI and Lab ID C. diff reporting
Speaker: Kyle Armstrong, DO
Emergency and Inpatient Psychiatry
Disclosures: None
Objectives:
•Discuss screening, brief intervention/treatment, and referral to treatment model of care
•Overview of motivational interviewing and other brief treatment modalities
•Review various other treatment and recovery models for the treatment of substance use disorder
Speaker: Jane Ellis, MD, PhD
Department of Gynecology and Obstetrics
Division of Maternal-Fetal Medicine
Emory University School of Medicine
Disclosures: None
Objectives:
•Describe basic terminology important in understanding maternal mortality
•Review current status of maternal deaths worldwide, in US and in Georgia
•Highlight Georgia’s leading causes of pregnancy-related and pregnancy-associated deaths
•Review recommendations for reducing maternal deaths from Georgia’s Maternal Mortality Review Committee
Speaker: Dr. Konstantin Zubelevitskiy
No disclosures
Objectives:
•Introduce the ICU Liberation initiative
•Define PADIS guidelines and ABCDEF bundle
•Discuss the importance of pain management in the ICU setting
•Compare valid and reliable pain assessment tools
•Identify challenges in assessing pain
•Introduce effective strategies to prevent and manage pain
•Discuss working with opioid-dependent patients
•Review the case scenario
Speaker: Dr. Abhishek Singh
No Disclosures
Objectives:
•Outline the DSM 5 criteria for substance use disorders
•Identify etiologies and pathophysiology of Alcohol use disorders and Stimulant Use disorder
•Describe treatment options for Alcohol Use disorder various substance use disorders
•Identify how interprofessional team strategies can improve patient outcomes in SUD
•Identify and discuss new challenges in SUD
Title: Cardiology Grand Rounds: Cerebral Protection for TAVR Evidence and Rationale
Speaker: Alexandra Lansky, MD
Professor of Medicine, Section of Cardiology
Yale School of Medicine
Disclosures: Grant/Research: Emboline, Emblok, Boston Scientific
Consultant: MedAlliance, Abiomed, Boston Scientific
Objectives:
- To review the incidence of stroke after TAVR
- To review the timing and mechanisms of stroke after TAVR
- To review the evidence for Cerebral Embolic Protections
- To review future innovations in cerebral embolic protection
Title: DEA Pain Management and Pharmacokinetics
Speakers: Dr. Leena Dutta and Dr. Alix Schnibben
Disclosures: Dr. Dutta - none
Dr. Schnibben - speakers bureau: GlaxoSmithKline Pharmaceutical vaccines
Objectives:
- Review history of opioids
- Define pharmacokinetics/pharmacodynamics of opioids
- Understand different types of pain and how to assess
- Consider when to manage pain with non-pharmacologic
- Recite how to use the WHO ladder to start pharmacologic management of pain
- Understand the difference between tolerance, dependence, pseudo-addiction and addiction
Comments
Download from Google Play
Download from App Store
United States